Kawasaki disease and giant coronary artery aneurysms: the role of echocardiography from diagnosis through follow-up.

Echocardiography

Department of Anesthesiology and Critical Care Medicine, Division of Cardiothoracic Anesthesiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Published: August 2016

Kawasaki disease is an acquired vasculitis that can affect the coronary arteries placing the patient at risk for coronary artery thrombosis, myocardial ischemia and infarction. The risk of complications related to coronary artery involvement persists for years despite recovery from the acute illness phase. The risk of late coronary disease progression necessitates long term follow-up generally accomplished by non-invasive echocardiography in pediatric patients. We review the utility of echocardiography in patients with Kawasaki disease as it relates to initial management, risk stratification and follow-up of these children.

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.13271DOI Listing

Publication Analysis

Top Keywords

kawasaki disease
12
coronary artery
12
coronary
5
disease giant
4
giant coronary
4
artery aneurysms
4
aneurysms role
4
role echocardiography
4
echocardiography diagnosis
4
diagnosis follow-up
4

Similar Publications

Objectives: The objective of this study was to investigate the role of infections in the pathogenesis of Kawasaki disease.

Methods: The investigation was a nationwide epidemiological case-control study, comprising all cases of Kawasaki disease diagnosed in Sweden 1987-2018. Controls were randomly sampled from the general population, matched on sex, age, and area of residency.

View Article and Find Full Text PDF

Background: Rare cases of Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) have been reported following the coronavirus disease 2019 (COVID-19) vaccination; however, the association between COVID-19 vaccination and the risk of developing KD/MIS-C has not yet been established.

Methods: We conducted a self-controlled case series analysis using a large-linked database that connects the COVID-19 immunization registry with nationwide claims data. We identified individuals aged < 18 years who received their initial COVID-19 vaccination and had a KD/MIS-C diagnosis with a prescription for intravenous immunoglobulin or corticosteroids between October 18, 2021, and April 15, 2023.

View Article and Find Full Text PDF

The etiology of Kawasaki disease (KD) has not yet been completely elucidated. We evaluated the temporal association between respiratory pathogens and KD incidence and the association between respiratory pathogens and treatment responsiveness in patients with KD. This retrospective study was conducted to compare the number of symptomatic children with pathogens detected using multiplex PCR tests with the number of KD cases.

View Article and Find Full Text PDF

Kawasaki disease, traditionally classified as medium vessel vasculitis, is known for the preferential involvement of coronary arteries. Infrequently, large systemic arteries might be involved and may affect the prognosis. Here, we present an infant with Kawasaki disease who had extensive involvement of large vessels such as the abdominal aorta and medium vessels of the extremities, along with giant coronary artery aneurysms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!